0001437749-18-022763 Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 31st, 2018 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 30, 2018, between Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

AutoNDA by SimpleDocs
STRICTLY CONFIDENTIAL Innovus Pharmaceuticals, Inc.
Letter Agreement • December 31st, 2018 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SERIES [A/B/C PREFUNDED] COMMON STOCK PURCHASE WARRANT
Innovus Pharmaceuticals, Inc. • December 31st, 2018 • Pharmaceutical preparations

THIS SERIES [A/B/C PREFUNDED] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) [and on or prior to 5:00 p.m. (New York City time) on eighteen (18) month anniversary of the Reverse Stock Split Date]1 [and on or prior to 5:00 p.m. (New York City time) on five and a half (5.5) year anniversary of the Reverse Stock Split Date]2 [and until this Warrant is exercised in full]3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sec

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 31st, 2018 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 30, 2018, between Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

Time is Money Join Law Insider Premium to draft better contracts faster.